You are here

It's time to catalyse capital to boost biomed sector

COVID-19 has been the rudest wake-up call to the importance of biomedical research. One in 200 diseases known to science have meaningful treatments, while drug candidates face a 10,000-to-one odds of making it from research labs to pharmacy shelves. As a never-ending pipeline of new viruses...

BT is now on Telegram!

For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes